Institut Jules Bordet

Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency (2023) Burghelea M, Bakkali Tahiri J, Dhont J, Kyndt M, Gulyban A, Szkitsak J, Bogaert E, et al. Journal article A comprehensive quality assurance program for four-dimensional computed tomography in radiotherapy (2023) Bakkali Tahiri J, Kyndt M, Dhont J, Gulyban A, Szkitsak J, Bogaert E, Reynaert N, Burghelea M Journal article The 3rd ESTRO-EFOMP core curriculum for medical physics experts in radiotherapy (2022) Garibaldi C, Essers M, Heijmen B, Bertholet J, Koutsouveli E, Schwarz M, Bert C, et al. Journal article Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry (2021) Hernandez-Boluda JC, Pereira A, Kroeger N, Cornelissen JJ, Finke J, Beelen D, De Witte M, et al. Journal article Resection of pancreatic cancer in Europe and USA: An international large-scale study highlighting large variations (2019) Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, Van Der Geest L, Lemmens V, et al. Journal article Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) (2017) Loibl S, De La Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, et al. Journal article Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations (2017) Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, Van Der Geest L, Lemmens V, et al. Journal article Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group (2016) Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, et al. Journal article Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (2014) Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, et al. Journal article PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014) Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al. Journal article